Apparatus and method for antitachycardia pacing in dual chamber arrhythmia control system

• US 4,998,974 A
• Filed: 01/05/1990
• Issued: 03/12/1991
• Est. Priority Date: 01/05/1990
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Telectronics Pacing Systems, Inc (Abbott Laboratories Incorporated)
• Inventors: Aker, David
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): Getzow, Scott M.
• Application Number:
  US07/462,499
• Time in Patent Office: 431 Days
• Field of Search: 128/419 PG
• US Class Current: 607/4
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions

Abstract

Apparatus and method of antitachycardia pacing in a duel chamber pacing device including means for or steps of detecting the presence of a tachycardia, measuring the tachycardia cycle length, determining a VA interval value less than or equal to the tachycardia cycle length, determining an initial value of the AV delay interval, delivering pulses to the ventricle and to the atrium until the expiration of N VA intervals and N AV intervals thereby completing a first train of pulses, delivering a series of M trains of pulses similar to said first train pulses, and varying the AV delay interval value from the initial value at least once prior to the completion of the series of M trains of pulses. Monitoring of instrinsic QRS complexes between pulse trains is performed. If the tachyarrhythmia is deemed to be accelerating, one of cardioversion or defibrillation may be applied.

Claims

1. A dual chamber antitachycardia pacing device for the reversion of tachycardias in a heart comprising:

means for detecting tachycardia, means for measuring cycle length of said tachycardia, means for determining a VA interval value less than or equal to the tachycardia cycle length, means for determining an initial value AV delay interval, pulse generating means responsive to said tachycardia detecting means for generating heart stimulating pulses for the atrium and for the ventricle, said pulse generating means including means for delivering a series of M pulse trains with each train consisting of a total of 2N pacing pulses delivered in an alternating sequence to the ventricle and to the atrium, so that timing of said delivered pulses is in accordance with the values of the VA interval and the AV interval, whereby each train comprises the delivery of a pacing pulse to the atrium at the expiration of each of N VA delay intervals and a pacing pulse to the ventricle at the expiration of each of N AV delay intervals, and means for varying said AV delay interval from said programmed initial value at least once prior to completion of said series of M pulse trains.

2. A dual chamber antitachycardia pacing device according to claim 1 further comprising means for confirming the presence of a tachycardia, wherein said pulse generating means is responsive to said confirming means.

3. A dual chamber antitachycardia pacing device according to claim 1 wherein said determined VA interval is a percentage of the tachycardia cycle length.

4. The dual chamber antitachycardia pacing device according to claim 3 wherein said percentage of the tachycardia cycle length is in the range of thirty to one hundred percent.

5. A dual chamber antitachycardia pacing device according to claim 1 further comprising means for incrementing said initial value AV delay interval at least once prior to said completion of said series of pulse trains to a final value AV delay interval.

6. A dual chamber antitachycardia pacing device according to claim 5 further comprising means for storing an average AV delay during previous sinus rhythm, wherein said final value AV delay interval is a function of and equal to or less than one hundred percent of the previous stored average AV delay during sinus rhythm.

7. A dual chamber antitachycardia pacing device according to claim 1 including means for providing dual chamber overdrive pacing at the completion of said M trains of pulses.

8. A dual chamber antitachycardia pacing device according to claim 7 further comprising means for programming a duration of said dual chamber overdrive pacing.

9. A dual chamber antitachycardia pacing device according to claim 7 further comprising means for storing an average AV delay during previous sinus rhythm, wherein said overdrive pacing includes an AV delay interval which is a function of and less than or equal to one hundred percent of the previous stored average AV delay during sinus rhythm.

10. A dual chamber antitachycardia pacing device according to claim 7 further comprising means for storing an average AV delay during previous sinus rhythm, wherein said dual chamber overdrive pacing includes a VA interval which is a function of and less than or equal to one hundred percent of the previous stored average VA delay interval during sinus rhythm.

11. A dual chamber antitachycardia pacing device according to claim 1 wherein said determined VA interval remains fixed during said series of M trains.

12. A dual chamber antitachycardia pacing device according to claim 1 further comprising means for varying said determined VA interval during the series of M trains.

13. A dual chamber antitachycardia pacing device according to claim 1 wherein said initial value AV delay interval is less than 20 ms.

14. A dual chamber antitachycardia pacing device according to claim 1 wherein said initial value AV delay interval is less than or equal to 60 ms.

15. A dual chamber antitachycardia pacing device according to claim 1 wherein N is fixed during said series of M trains.

16. A dual chamber antitachycardia pacing device according to claim 15 wherein N is between 1 and 10.

17. A dual chamber antitachycardia pacing device according to claim 1 further comprising means for varying N during said series of M trains.

18. A dual chamber antitachycardia pacing device according to claim 16 wherein N is between 1 and 10.

19. A dual chamber antitachycardia pacing device according to claim 1 wherein M is between 1 and 100.

20. A dual chamber antitachycardia pacing device according to claim 1 in combination with an implantable pacemaker cardioverter/defibrillator device.

21. A dual chamber antitachycardia pacing device according to claim 20 wherein said pacemaker includes at least one of single chamber and dual chamber bradycardia pacing.

22. A dual chamber antitachycardia pacing device according to claim 1 wherein said device includes means for sensing inherent QRS complexes during delivery of said trains of pacing pulses, means for determining an acceleration detection cycle length value less than said tachycardia cycle length, means for measuring the cycle lengths of said sensed QRS complexes, and means for delivering at least one of cardioversion and defibrillation therapy when a programmed number of said cycle lengths of said sensed QRS complexes are less than said acceleration detection cycle length.

23. The dual chamber antitachycardia pacing device according to claim 1 wherein said means for determining an initial value AV delay interval includes programming means for programming said interval.

24. A method of antitachycardia pacing in a dual chamber pacing device comprising the steps of:

measuring cycle length of the tachycardia,

determining a VA interval value less than or equal to the tachycardia cycle length,

determining an initial value of the AV delay interval,

delivering a pulse to the ventricle,

delivering a pulse to the atrium at the expiration of said determined VA interval value,

delivering a pulse to the ventricle at the expiration of said AV interval value,

repeating pulse delivery to the atrium and the ventricle until the expiration of N VA intervals and N AV intervals thereby completing a first train of pulses,

delivering a series of M trains of pulses similar to said first train of pulses,

varying said AV delay interval value from the initial value at least once prior to the completion of said series of M trains of pulses.

25. The method of antitachycardia pacing in a dual chamber pacing device according to claim 24 further comprising the step of confirming the presence of tachycardia prior to commencing antitachycardia pacing.

26. The method of antitachycardia pacing in a dual chamber pacing device according to claim 24 wherein said initial value of the AV delay interval is determined by programming.

27. The method of antitachycardia pacing in a dual chamber pacing device according to claim 24 wherein said determined VA interval is a percentage of the tachycardia cycle length.

28. The method of antitachycardia pacing in a dual chamber pacing device according to claim 27 wherein said percentage is in the range of fifty to one hundred percent.

29. A method of antitachycardia pacing in a dual chamber pacing device according to claim 24 wherein said initial value AV delay interval is incremented at least once prior to said completion of trains to a final value AV delay interval.

30. A method of antitachycardia pacing in a dual chamber pacing device according to claim 29 further comprising the step of storing a previous average AV delay interval during sinus rhythm, wherein said final value AV delay interval is a function of and less than or equal to one hundred percent of the previous stored average AV delay during sinus rhythm.

31. A method of antitachycardia pacing in a dual chamber pacing device according to claim 29 further comprising the step of providing dual chamber overdrive pacing at the completion of said M trains of pulses.

32. A method of antitachycardia pacing in a dual chamber pacing device according to claim 31 further comprising the step of programming a duration of said dual chamber overdrive pacing.

33. A method of antitachycardia pacing in a dual chamber pacing device according to claim 31 further comprising the step of storing a previous average AV delay interval during sinus rhythm wherein said dual chamber overdrive pacing includes an AV delay interval which is a function of and less than or equal to one hundred percent of the previous stored average AV delay during sinus rhythm.

34. A method of antitachycardia pacing in a dual chamber pacing device according to claim 31 further comprising the step of storing a previous average AV delay interval during sinus rhythm wherein said dual chamber overdrive pacing includes a VA interval which is a function of and less than or equal to one hundred percent of the previous stored average VA delay interval during sinus rhythm.

35. A method of antitachycardia pacing in a dual chamber pacing device according to claim 24 wherein said determined VA interval remains fixed during said series of M trains.

36. A method of antitachycardia pacing in a dual chamber pacing device according to claim 24 further comprising varying said VA interval during said series of M trains.

37. A method of antitachycardia pacing in a dual chamber pacing device according to claim 24 wherein said initial value AV delay interval is less than 20 ms.

38. A method of antitachycardia pacing in a dual chamber pacing device according to claim 24 wherein said initial value AV delay interval is less than or equal to 60 ms.

39. A method of antitachycardia pacing in a dual chamber pacing device according to claim 24 wherein N is fixed during said series of M trains.

40. A method of antitachycardia pacing in a dual chamber pacing device according to claim 39 wherein N is between 1 and 10.

41. A method of antitachycardia pacing in a dual chamber pacing device according to claim 24 further comprising varying N during said series of M trains.

42. A method of antitachycardia pacing in a dual chamber pacing device according to claim 41 wherein N is between 1 and 10.

43. A method of antitachycardia pacing in a dual chamber pacing device according to claim 24 wherein M is between 1 and 100.

44. A method of antitachycardia pacing in a dual chamber pacing device according to claim 24 further comprising performing at least one of cardioversion and defibrillation.

45. A method of antitachycardia pacing in a dual chamber antitachycardia pacing device according to claim 44 further comprising providing at least one of single chamber or dual chamber bradycardia pacing.

46. A method of antitachycardia pacing in a dual chamber antitachycardia pacing device according to claim 44 further comprising the steps of sensing inherent QRS complexes during the delivery of said trains of pacing pulses, determining an acceleration detection cycle length value less than said tachycardia cycle length, measuring cycle lengths of said sensed QRS complexes, and delivering at least one of cardioversion and defibrillation therapy when a programmed number of said cycle lengths of said sensed QRS complexes are less than said acceleration detection cycle length.

47. A dual chamber antitachycardia pacing device for the reversion of tachycardias comprising:

means for detecting tachycardia, means for measuring cycle length of said tachycardia, pulse generating means responsive to said tachycardia detecting means for generating heart stimulating pulses for the atrium and for the ventricle, said pulse generating means including means for delivering a series of pacing pulse trains, means for sensing inherent QRS complexes during delivery of said trains of pacing pulses, means for determining an acceleration detection cycle length value less than said tachycardia cycle length, means for measuring cycle lengths of said sensed QRS complexes, and means for delivering at least one of cardioversion and defibrillation therapy when a number of said cycle lengths of said sensed QRS complexes are less than said acceleration detection cycle length.

48. A method of antitachycardia pacing in a dual chamber pacing device comprising the steps of:

detecting a tachycardia, measuring cycle length of the tachycardia, delivering trains of antitachycardia pacing pulses to the atrium and to the ventricle, sensing inherent QRS complexes during the delivery of said trains of pacing pulses, determining an acceleration detection cycle length value less than said tachycardia cycle length, measuring cycle lengths of said sensed QRS complexes, and delivering at least one of cardioversion and defibrillation therapy when a number of said cycle lengths of said sensed QRS complexes are less than said acceleration detection cycle length.